Omnicell (OMCL) : The traders have covered their outstanding shorts in Omnicell (OMCL) to the tune of -67,631 shares, a change of -5.4%. As on Jul 29, 2016, the outstanding shorts on the stock were 1,243,808 shares, however, by August 15, 2016, the shorts had reduced to 1,176,177 shares. The covering shows that the traders dont believe that a large downside exists in the stock from current levels. The open short positions equal 3.4% of the free float of the stock. It takes 8 days to cover the outstanding short positions. The stock has an average daily volume of 149,127 shares. The short interest information was released on Wednesday Aug 24th after the market close.
Omnicell (NASDAQ:OMCL): The stock was completely flat for the day, closing at $37.49 on Wednesday. The flat closing masks the intraday volatility in the stock. After opening at $37.58, the stock touched an intraday high of $37.72 and a low of $37.34. Neither the bulls nor the bears asserted their supremacy at close, due to which the stock closed completely flat. The stock previously closed at $37.49. The total trading volume on Wednesday was 88,255.
In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director officer (Chairman, President, and CEO) of Omnicell, Inc, Lipps Randall A had sold 37,425 shares worth of $1,398,198 in a transaction dated August 10, 2016. In this transaction, 37,425 shares were sold at $37.36 per share.
Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company has two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is organized around the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. The Companys products include OmniRx, SinglePointe, AnywhereRN, OptiFlex MS, OptiFlex CL, AccuFlex, Autobond, AutoGen, and SureSeal, among others.